Going Concern (Details Narrative) - USD ($)	3 Months Ended	9 Months Ended	119 Months Ended
	Jun. 30, 2016	Jun. 30, 2016	Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Non-cash gain upon deconsolidation ofEntest Biomedical, Inc.			$ 312,327
Net Losses			37,164,777
Equity in Net Losses of Entest Biomedical, Inc.			$ 663,649
Proceeds from issuance of equity securities	$ 329,750	$ 1,154,751
Proceeds from issuance of convertible debentures	$ 50,000	$ 150,000